TWiM explains how ticagrelor alters the membrane of S. aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance, and the development of a novel continuous disinfectant technology that decreases healthcare-associated infections in ICUs by 70%.
Hosts: , , and .
Subscribe to TWiM (free) on , , , , or by
Become a of TWiM.
Links for this episode
- (mBio)
- Novel (Am J Inf Control)
- UVC-LED to (Appl Envir Micro)
- systems (ACS Photonics)
- area (CDC)
- Take the TWiM Listener survey!
